Skip to main content
Standard BioTools Inc. (LAB)
NASDAQ: LAB · Real-Time Price · USD
1.600
-0.020 (-1.23%)
At close: Nov 22, 2024, 4:00 PM
1.680
+0.080 (5.00%)
After-hours: Nov 22, 2024, 6:04 PM EST

Standard BioTools Revenue

Standard BioTools had revenue of $44.97M in the quarter ending September 30, 2024, with 77.27% growth. This brings the company's revenue in the last twelve months to $155.90M, up 48.23% year-over-year. In the year 2023, Standard BioTools had annual revenue of $106.34M with 8.57% growth.

Revenue (ttm)
$155.90M
Revenue Growth
+48.23%
P/S Ratio
2.87
Revenue / Employee
$289,243
Employees
539
Market Cap
595.61M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023106.34M8.39M8.57%
Dec 31, 202297.95M-32.63M-24.99%
Dec 31, 2021130.58M-7.56M-5.47%
Dec 31, 2020138.14M20.90M17.83%
Dec 31, 2019117.24M4.28M3.79%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Axogen 180.86M
Surmodics 126.08M
CureVac 70.57M
Simulations Plus 70.01M
ABIVAX Société Anonyme 9.68M
IGM Biosciences 2.92M
Revenue Rankings

LAB News

More News